Institutional owners may take dramatic actions as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) recent 12% drop adds to one-year losses

Analyzing analyst forecasts and ownership data can help predict a company's future performance. Institutional investors, holding 65% of Coherus BioSciences, greatly impact stock prices. With hedge funds and top shareholders involved, assessing different investor types is crucial for informed investment decisions.